Literature DB >> 15782872

National serosurvey of poliovirus immunity in Australia, 1996-99.

Heather F Gidding1, Josephine L Backhouse, Gwendolyn L Gilbert, Margaret A Burgess.   

Abstract

OBJECTIVE: To measure immunity to poliovirus types 1, 2 and 3 in the Australian population.
METHODS: Sera were collected opportunistically from laboratories around Australia between 1996 and 1999. A representative sample by age and gender was tested for neutralising antibodies to poliovirus types 1, 2 and 3. A titre of > or = 8 was considered antibody positive and indicative of immunity.
RESULTS: Of the 1,813 sera tested, 82% were antibody positive for poliovirus type 1 and 88% were positive for type 2. Immunity to type 3 poliovirus was lower overall (74%) and especially in school-aged children and young adults. For all three poliovirus types, there were more females immune than males and immunity peaked in the 2-4 years age group. The proportion of the population immune to all three types was 59%, and 3% were negative for all three types. CONCLUSIONS AND IMPLICATIONS: This is the first national serosurvey for immunity to poliovirus in Australia. Herd immunity is probably sufficient to prevent generalised outbreaks due to type 1 and 2 poliovirus, but this may not be the case for type 3. However, localised outbreaks of any poliovirus type could still occur following reintroduction unless uniformly high levels of vaccination coverage are maintained. Ongoing serosurveillance is required following the recent change back to inactivated polio vaccine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15782872     DOI: 10.1111/j.1467-842x.2005.tb00748.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  4 in total

1.  Polio eradication in India: the way forward.

Authors:  Subhash C Arya; Nirmala Agarwal
Journal:  Indian J Pediatr       Date:  2007-12       Impact factor: 1.967

2.  Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012.

Authors:  B Mao; K Chheng; K Wannemuehler; E Vynnycky; S Buth; S C Soeung; S Reef; W Weldon; L Quick; C J Gregory
Journal:  Epidemiol Infect       Date:  2014-11-06       Impact factor: 4.434

3.  Characterization of antibodies in human immunoglobulin products from different regions worldwide.

Authors:  Alexandra Serra; Núria Marzo; Berta Pons; Pau Maduell; Maite López; Salvador Grancha
Journal:  Int J Infect Dis       Date:  2021-01-29       Impact factor: 3.623

4.  An evaluation of the sensitivity of acute flaccid paralysis surveillance for poliovirus infection in Australia.

Authors:  Rochelle E Watkins; P Anthony J Martin; Heath Kelly; Ben Madin; Charles Watson
Journal:  BMC Infect Dis       Date:  2009-09-30       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.